Back to Clinical Trials Overview

Your search for "Gastroenterology" returned 19 results:


A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Principal Investigator(s): Jean-Frederic Colombel

An Open-Label Extension of Study SERES-004 Evaluating SER-109 in Patients with Recurrent Clostridium difficile Infection
Principal Investigator(s): Ari Grinspan

A Multicenter, Open-Label Study to Evaluate the Long Term Efficacy, Safety, and Tolerability of Repeated Administration of Adalimumab in Subjects with Crohn's Disease
Principal Investigator(s): James Marion

A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects with Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis
Principal Investigator(s): Ioannis Oikonomou

A Randomized, Double-Blind, Multicenter Study to Explore The Effect Of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn's Disease
Principal Investigator(s): Bruce Sands

A Multicenter Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regiments in Subjects with Moderately Severely Active Crohn's Disease and Evidence of Mucosal Ulceration
Principal Investigator(s): James Marion

Bacterial Transmission In Utero and IBD Risk: The MECONIUM Study
Principal Investigator(s): Inga Peter

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis
Principal Investigator(s): Jean-Frederic Colombel

A multi-center, open-label study of CP-690,550 in subjects with moderate to severe ulcerative colitis (A3921139)
Principal Investigator(s): James Marion

A RandomizEd, Double-Blind, Placebo-COntrolled, Parallel-Group Study of SER-109 to Prevent Recurrent ClostRidium difficile Infection
Principal Investigator(s): Ari Grinspan

A Combined Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluating the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis
Principal Investigator(s): James Marion

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Dupilumab in Adult Patients with Active Eosinophilic Esophagitis
Principal Investigator(s): Chehade, Mirna

Food Protein-Induced Enterocolitis Syndrome - FPIES (ages 6 months-21 years)
Principal Investigator(s): Nowak-Wegrzyn, Anna

A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Oral CP-690,550 as a maintenance therapy in subjects with moderate to severe Ulcerative Colitis
Principal Investigator(s): James Marion

A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects With Ulcerative Colitis
Principal Investigator(s): Bruce Sands

A Multicenter Long-term Extension Study to Further Evaluate the Safety and Tolerability of Telotristat Etiprate (LX1606)
Principal Investigator(s): Richard Warner

Integrative approaches to managing Irritable Bowel Syndrome (IBS)
Principal Investigator(s): Elizabeth McDonald, MS, RDN, CSSD and Benjamin Kligler, MD, MPH

A Double-Blind Randomized Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
Principal Investigator(s): James Marion

A 24- Week Study of the Efficacy and Safety of Teduglutide in Subjects with Parental Nutrition-Dependent Short Bowel Syndrome CL0600-020
Principal Investigator(s): Iyer, Kishore